MEDTRONIC I NEUROVASCULAR

Medtronic is the American corporation, the fourth largest in the list of global companies engaged in the production of medical equipment and medical devices intended to restore health, alleviate pain and prolong people's lives. The company was founded in 1949. Thanks to the company's developments, more than fifty chronic diseases can be diagnosed and treated today.

Medtronic's head office is located in the suburbs of Minneapolis, Minnesota, USA. Outside the US, the major offices are located in Switzerland and Japan. In total, the company has more than 280 offices in 140 countries. The number of employees exceeds 49 thousand people, of which more than 10% are scientists and engineers engaged in developing new models of medical equipment. To date, Medtronic has registered more than 28 thousand patents. Medtronic performs a full cycle of manufacturing medical devices and equipment: from the concept to its implementation in mass production.

In Russia, the official representative office of Medtronic has been working since 2003 and presents technologies for treatment in the following areas: arrhythmology, cardiosurgery, vascular surgery, invasive cardiology and radiology, intensive care, neurosurgery, diabetology, intraoperative navigation and spine surgery. 

Medtronic systematically invests in high-tech, promising medical productions. On January 27, 2015, Medtronic announced the successful acquisition of Covidien plc.

The company's portfolio includes products of Medtronic (Covidien plc.) for Neurovascular angioplasty and Embolotherapy